期刊文献+

老年高血压1746例社区治疗分析

Analysis on community treatment of 1 746 elderly patients with hypertension
下载PDF
导出
摘要 目的:探讨农村社区对老年高血压患者综合干预治疗的重要性。方法:对社区内的1 746例老年高血压患者进行综合干预治疗的临床资料进行分析总结。结果:综合干预治疗后吸烟和大量饮酒人数、摄取食盐的量明显减少;血压控制达标率明显提高。控制血压最常用的药物是钙离子拮抗剂;心痛定使用率出现下降趋势,而服用洛活喜的患者显著增多;服用卡托普利显著减少,而服用依那普利与科素亚的患者却明显增多。结论:农村社区对老年高血压患者进行综合干预治疗非常重要。加强健康教育、引导患者建立良好的生活习惯和加强治疗的依从性是农村社区防治老年高血压的最佳方案。 Objective:To explore the importance of comprehensive intervention therapy for elderly patients with hypertension inrural communities.Methods:The clinical data of 1746 cases of elderly patients with hypertension in the community treated bycomprehensive intervention therapy were analyzed and summarized.Results:After the comprehensive intervention treatment,thenumber of smokers and a large number of drinking,the amount of salt intake were significantly reduced.The compliance rate ofblood pressure control increased significantly.The most commonly used drugs to control blood pressure was calcium antagonist,there was a decrease in the rate of use of nifedipine,while the number of patients taking norvasc was significantly increased.Patients taking captopril decreased significantly,while taking enalapril and losartan increased significantly.Conclusion:Comprehensive intervention therapy is very important for elderly patients with hypertension in rural communities,strengthenhealth education,guide patients to establish good habits and strengthen the treatment compliance,which are the best schemes ofprevention and treatment for elderly patients with hypertension in rural communities.
作者 陈淑萍 夏翠英 Chen Shuping;Xia Cuiying(General Consulting Room,the Health Center of Mapo Town,Shunyi District,Beijing 101300;Department of General Medicine,Konggang Hospital of Shunyi District,Beijing 101318)
出处 《中国社区医师》 2016年第8期174-175,共2页 Chinese Community Doctors
关键词 老年人 高血压 综合干预 达标率 Elderly Hypertension Comprehensive intervention Standard rate
  • 相关文献

参考文献2

二级参考文献17

  • 1黄村华,陈金山,黄蕾,丘毅铭.高血压患者药物治疗依从性调查[J].实用医学杂志,2005,21(1):84-85. 被引量:66
  • 2卫生部心血管病防治研究中心.中国心血管病报告2006.北京:中国大百科全书出版社,2007.
  • 3Liu L, Zhang Y, Liu G, et al. FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long- term placebo-controlled trial in Chinese hypertensive patients. J Hypertens, 2005,23 : 2157-2572.
  • 4Julius S, Kjeldsen SE, Weber M, et al. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 2004,363:2022-2031.
  • 5Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet ,2003,361 : 1149-1158.
  • 6Weber MA, Bakris GL, Dahlof B, et al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press ,2007,16 : 13-19.
  • 7Wang JG, Li Y, Franklin SS, et al. Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers : a quantitative overview. Hypertension, 2007,50 : 181 - 188.
  • 8Makino H, Haneda M, Babazono T, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes : a post-hoc analysis of The Incipient to Overt: Angiotensin Ⅱ Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertens Res,2008,31:657-664.
  • 9Sharma A, Bagchi A, Kinagi SB, et al. Results of a comparative, phase Ⅲ, 12-week, muhicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed- dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage Ⅱ hypertension. Clin Ther, 2007,29 : 2667 -2676.
  • 10Chrysant SG. Amlodipine/ARB fixed-dose combinations for the treatment of hypertension : focus on amlodipine/olmesartan combination. Drugs Today (Barc) ,2008,44:443-453.

共引文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部